Hemorrhage Countermeasure Evaluation Capabilities RFI
| Location: | Federal |
|---|---|
| Posted: | Apr 9, 2026 |
| Due: | May 4, 2026 |
| Agency: | DEPT OF DEFENSE |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | DARPA-SN-26-61 |
| Publication URL: | To access bid details, please log in. |
Follow
Active
Contract Opportunity
Notice ID
DARPA-SN-26-61
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office
DEF ADVANCED RESEARCH PROJECTS AGCY
General Information
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Apr 09, 2026 11:07 am EDT
- Original Response Date: May 04, 2026 04:00 pm EDT
- Inactive Policy: Manual
- Original Inactive Date: May 05, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AC12 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency
(DARPA) seeks input from industry and academia regarding capabilities for providing independent verification and validation, clinical trial, and commercialization support for hemorrhage countermeasures. This Request for Information (RFI) is a preliminary step to identify potential partners capable of providing third-party assessments of safety and efficacy of potential hemorrhage countermeasures and assisting in development strategies to ensure said products transition from the laboratory to civilian and government markets after research, development, testing, and evaluation (RDT&E) efforts have ended. DARPA is particularly interested in respondents who can address all the above task domains to allow one provider to have comprehensive knowledge about the data for efficiency and to tailor commercialization and regulatory strategies.
(DARPA) seeks input from industry and academia regarding capabilities for providing independent verification and validation, clinical trial, and commercialization support for hemorrhage countermeasures. This Request for Information (RFI) is a preliminary step to identify potential partners capable of providing third-party assessments of safety and efficacy of potential hemorrhage countermeasures and assisting in development strategies to ensure said products transition from the laboratory to civilian and government markets after research, development, testing, and evaluation (RDT&E) efforts have ended. DARPA is particularly interested in respondents who can address all the above task domains to allow one provider to have comprehensive knowledge about the data for efficiency and to tailor commercialization and regulatory strategies.
Attachments/Links
Contracting Office Address
- 675 NORTH RANDOLPH STREET
- ARLINGTON , VA 222032114
- USA
Primary Point of Contact
- Lt. Cmdr. Robert Murray, DARPA/BTO
- DARPA-SN-26-61@darpa.mil
Secondary Point of Contact
- Apr 09, 2026 11:07 am EDTSpecial Notice (Original)
Related Document
| Apr 15, 2026 | [Special Notice (Updated)] Hemorrhage Countermeasure Evaluation Capabilities RFI |
Daily notification on new contract opportunities
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...purposes only. NETL is soliciting data, information, and expert commentary from the United ...
ENERGY, DEPARTMENT OF
Bid Due: 6/19/2026
...suite for quantum network component and protocol testing, verification, and characterization. Line... network ...
COMMERCE, DEPARTMENT OF
Bid Due: 6/12/2026
..., no later than Friday June 5th 2026 at 5:00pm EST. There is ...
DEPT OF DEFENSE
Bid Due: 6/05/2026
...data and therefore cannot provide drawings, specifications, or schematics for these parts. 6... ...
HOMELAND SECURITY, DEPARTMENT OF
Bid Due: 12/05/2026
* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.